This is an aggregated industry headline. Read the full story at FiercePharma →
Germany backs off plan to install variable discount pricing on drugs: report
Following criticism from drugmakers, Germany has scrapped its plan to install a program that would have reduced the prices of branded pharmaceuticals through a variable structure, according to a report from Reuters.
By FiercePharma
· Jun 16, 2026
· via FiercePharma
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFierceBiotech ↗
The company's SPY002 prompted a 10.7-point reduction from baseline levels in patients' Robart's Histopathology…
The WeekBriefing
The FDA approved Colorado’s proposal to import certain Canadian drugs, aiming to curb costs for state resident…
The WeekDrug Channels ↗
By Bryce Platt, PharmD For years, Medicare Part D plans often preferred high-list/high-rebate branded multiple…